Published July 5, 2021 | Version v1
Project deliverable Open

Core evidence elements for generating medication safety evidence for pregnancy using population-based data (D1.2)

  • 1. University hospital of Toulouse
  • 2. Glaxo Smith Kline Research and Development LTD

Description

The purpose of this deliverable is to select, identify, and establish core evidence elements, as well as lay the foundations and analytical considerations to evaluate medication utilisation and safety in pregnancy. By utilizing population-based data, it will inform healthcare professionals together with their patients and at the same time satisfy the requirements for the possible incorporation in product labels.

Files

821520_ConcePTION - D1.2 Report on the core evidence elements for generating medication safety evidence for pregnancy using population-based data.pdf

Additional details

Funding

ConcePTION – Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation 821520
European Commission